Functional Equivalency in Human Somatic Cell Nuclear Transfer-Derived Endothelial Cells.
Soon-Jung ParkJi-Heon LeeSeul-Gi LeeJeoung Eun LeeJoseph SeoJong Jin ChoiTaek-Hee JungEun-Bin ChungHa Na KimJongil JuYun-Ho SongHyung-Min ChungDong Ryul LeeSung-Hwan MoonPublished in: Stem cells (Dayton, Ohio) (2019)
The derivation of human embryonic stem cells (hESCs) by somatic cell nuclear transfer (SCNT) has prompted a re-emerging interest in using such cells for therapeutic cloning. Despite recent advancements in derivation protocols, the functional potential of CHA-NT4 derived cells is yet to be elucidated. For this reason, this study sought to differentiate CHA-NT4 cells toward an endothelial lineage in order to evaluate in vitro and in vivo functionality. To initial differentiation, embryoid body formation of CHA-NT4 was mediated by concave microwell system which was optimized for hESC-endothelial cell (EC) differentiation. The isolated CD31+ cells exhibited hallmark endothelial characteristics in terms of morphology, tubule formation, and ac-LDL uptake. Furthermore, CHA-NT4-derived EC (human nuclear transfer [hNT]-ESC-EC) transplantation in hind limb ischemic mice rescued the hind limb and restored blood perfusion. These findings suggest that hNT-ESC-EC are functionally equivalent to hESC-ECs, warranting further study of CHA-NT4 derivatives in comparison to other well established pluripotent stem cell lines. This revival of human SCNT-ESC research may lead to interesting insights into cellular behavior in relation to donor profile, mitochondrial DNA, and oocyte quality. Stem Cells 2019;37:623-630.
Keyphrases
- endothelial cells
- induced apoptosis
- cell cycle arrest
- stem cells
- mitochondrial dna
- high glucose
- copy number
- induced pluripotent stem cells
- pluripotent stem cells
- cell therapy
- computed tomography
- cell death
- metabolic syndrome
- adipose tissue
- magnetic resonance imaging
- blood brain barrier
- brain injury
- human health
- cerebral ischemia
- risk assessment